SCHEMBL4670913

SCHEMBL4670913

CN(C)c1ccc(C2(c3ccccc3)C=Cc3c(ccc4cc(N(c5ccccc5)c5ccccc5)ccc34)O2)cc1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
CYP3A4 P08684 1/20 0.30
HIF1A Q16665 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670884 0.92 KDM1A (0.35) HTTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL29808393 0.89 KDM4E (0.31) HTTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL20565609 0.89 KDM4E (0.31) HTTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL4670918 0.89
SCHEMBL20565903 0.86 KDM4E (0.32) HTTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL7119512 0.85 KDM1A (0.39) HTTSMN1; SMN2ALDH1A1MEN1LMNA
SCHEMBL20565638 0.84 KDM4E (0.30) HTTSMN1; SMN2ALDH1A1HPGDKDM4E
Benzene SCHEMBL7253583 0.83 KDM1A (0.36) HTTSMN1; SMN2ALDH1A1HPGDCYP3A4
SCHEMBL4673295 0.83 HTT (0.32) HTTSMN1; SMN2
SCHEMBL29457328 0.82 GPR84 (0.32) GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461330-B1 3H-NAPHTHO[2,1-b]-PYRANE DERIVATIVES AND THEIR USE RODENSTOCK GMBH (DE) 2008-03-12 EP claimed
US-6967249-B2 Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith RODENSTOCK GMBH (DE) 2005-11-22 US claimed
US-20040267013-A1 Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith RODENSTOCK GMBH 2004-12-30 US claimed
EP-1461330-A1 3H-NAPHTHO 2,1-B]-PYRANE DERIVATIVES AND THE USE OF THE SAME Rodenstock GmbH (DE) 2004-09-29 EP claimed
WO-2003055872-A1 3H-NAPHTHO[2,1-B]-PYRANE DERIVATIVES AND THE USE OF THE SAME RODENSTOCK GMBH (DE) 2003-07-10 WO claimed
EP-1461330-B1 3H-NAPHTHO[2,1-b]-PYRANE DERIVATIVES AND THEIR USE RODENSTOCK GMBH (DE) 2008-03-12 EP disclosed
US-6967249-B2 Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith RODENSTOCK GMBH (DE) 2005-11-22 US disclosed
US-20040267013-A1 Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith RODENSTOCK GMBH 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040267013-A1 Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith RB1, TERB1, CRY2 HTT 473/4885SMN1; SMN2 4501/4885ALDH1A1 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.